Evaluation of Amphastar Pharmaceuticals stock downgraded after the last trading session.
(Updated on Nov 29, 2021)

The Amphastar Pharmaceuticals stock price fell by -2.16% on the last day (Monday, 29th Nov 2021) from $19.91 to $19.48. and has now fallen 4 days in a row. During the day the stock fluctuated 8.43% from a day low at $19.21 to a day high of $20.83. The price has fallen in 6 of the last 10 days and is down by -8.54% for this period. Volume has increased on the last day by 131 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 251 thousand shares were bought and sold for approximately $4.90 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.98% during the next 3 months and, with a 90% probability hold a price between $20.92 and $24.02 at the end of this 3-month period.

Signals & Forecast

There are few to no technical positive signals at the moment. The Amphastar Pharmaceuticals stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $20.45 and $19.82. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, November 12, 2021, and so far it has fallen -8.54%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss

Amphastar Pharmaceuticals finds support from accumulated volume at $18.68 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.62 between high and low, or 8.43%. For the last week, the stock has had a daily average volatility of 4.71%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Amphastar Pharmaceuticals stock A Buy?

The Amphastar Pharmaceuticals stock holds several negative signals and despite the positive trend, we believe Amphastar Pharmaceuticals will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -4.929

Remember To Visit Our YouTube Channel